AIM ImmunoTech terminates ATM equity distribution agreement with Maxim Group

AIM ImmunoTech Inc.

Mutual termination of Equity Distribution Agreement with Maxim Group effective August 15, 2026; no penalties incurred.
From April 2025 to July 2026, sold 3,200,736 shares for aggregate gross proceeds of approximately $2.8 million.
No additional shares will be sold under the agreement prior to termination; company may seek alternative financing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.